HEMATOPOIETIC

Clinical trials for HEMATOPOIETIC explained in plain language.

Never miss a new study

Get alerted when new HEMATOPOIETIC trials appear

Sign up with your email to follow new studies for HEMATOPOIETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a low-dose drug boost blood health in rare platelet disorder?

Disease control Recruiting now

This study tests whether low-dose sirolimus can safely improve blood cell function in adults with RUNX1 familial platelet disorder, a genetic condition that raises bleeding and leukemia risks. Six participants will take sirolimus and be monitored for side effects and changes in b…

Matched conditions: HEMATOPOIETIC

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 08, 2026 13:07 UTC

HEMATOPOIETIC

Get alerted when new HEMATOPOIETIC trials appear

Could a low-dose drug boost blood health in rare platelet disorder?